ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 143 filers reported holding ANIKA THERAPEUTICS INC in Q4 2013. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2016 | $236,000 | -26.9% | 4,391 | -39.1% | 0.01% | -44.4% |
Q1 2016 | $323,000 | -0.3% | 7,216 | -14.9% | 0.01% | +50.0% |
Q4 2015 | $324,000 | +30.1% | 8,482 | +24.8% | 0.01% | +20.0% |
Q3 2014 | $249,000 | -37.3% | 6,797 | -20.7% | 0.01% | -16.7% |
Q2 2014 | $397,000 | +18.9% | 8,569 | -2.2% | 0.01% | +50.0% |
Q4 2013 | $334,000 | – | 8,763 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Euclidean Technologies Management, LLC | 44,875 | $2,031,000 | 2.14% |
Parian Global Management LP | 102,705 | $4,648,000 | 1.16% |
CAPITAL MANAGEMENT CORP /VA | 93,035 | $4,211,000 | 1.15% |
Avidity Partners Management LP | 731,000 | $33,085,000 | 1.07% |
Sio Capital Management, LLC | 65,382 | $2,959,000 | 0.61% |
DIKER MANAGEMENT LLC | 21,835 | $988,000 | 0.50% |
Archon Capital Management LLC | 48,925 | $2,214,000 | 0.38% |
Caption Management, LLC | 362,800 | $16,420,000 | 0.37% |
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | 1,546,260 | $69,984,000 | 0.20% |
Boston Trust Walden Corp | 378,167 | $17,116,000 | 0.18% |